Heart bypass surgery with the Elana device
Part of Heart & circulation clinical trials.
This trial tests a new device called Elana that helps doctors connect blood vessels during heart bypass surgery. It may make the surgery easier and improve outcomes for people who need multiple bypasses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been scheduled for heart bypass surgery (CABG) and need more than one bypass, including one on the left side of the heart.
- You are willing to attend follow-up visits for up to 2 years after the surgery.
- You have not had heart surgery before.
- You are not a current smoker or have quit smoking less than a year ago.
- You do not have severe kidney failure, bleeding disorders, or recent stroke or mini-stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to connect a bypass graft during heart bypass surgery for people with blocked heart arteries. The goal is to see if the new graft can be safely placed and works well enough to improve outcomes compared with the standard approach.
This trial compares two types of heart bypass surgery for people with blockages in three main heart arteries. It tests a hybrid approach that combines a small incision bypass with a stent, versus a standard off-pump bypass. This may mean less recovery time for some patients.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
This study follows patients who have a type of heart bypass surgery called 'beating heart' CABG, where a special Getinge device is used to keep the heart pumping during the operation. It helps doctors learn more about how well these devices work in real-world use.
This trial tests a drug called EA-230 that may help people recover faster after heart bypass surgery. If you are having planned bypass surgery, this drug might shorten your hospital stay.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
Hear when a new Coronary Artery Bypass Grafting (CABG) Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.